Concentrix is trading 10.29% down at $28.85, as broader risk-off sentiment and renewed concerns over fiscal 2026 revenue expectations weigh on shares.

  • No new company-specific negative announcement was identified for September 8, 2026; restructuring pressures remain an investor overhang.
  • U.S. equities are lower amid renewed trade, oil, and interest-rate concerns.
  • Concentrix will release third-quarter results after market close on September 29, 2026.